STAT3 and autosomal dominant polycystic kidney disease: One study investigating STAT-targeting drugs for ADPKD therapies suggested pimozide inhibits STAT5, crizotinib inhibits STAT3 phosphorylation, and pyrimethamine inhibits STAT3 by dimerization (Strubl et al. 2020).